Temporal Association Between Atrial Fibrillation Burden in Cardiac Implantable Electronic Devices and the Risk of Heart Failure Hospitalization

被引:2
|
作者
Ahluwalia, Nikhil [1 ]
Koehler, Jodi [2 ]
Sarkar, Shantanu [2 ]
Vasudevan, Neethu [2 ]
Majumder, Shubha [2 ]
Landman, Sean R. [2 ]
Schilling, Richard J. [1 ]
机构
[1] St Bartholomews Hosp, Barts Hlth NHS Trust, London, England
[2] Medtronic Inc, Mounds View, MN USA
来源
关键词
atrial fibrillation; hospitalization; odds ratio; stroke; STRICT RATE CONTROL; TIME-COURSE; TACHYARRHYTHMIA; TACHYCARDIA; CARDIOMYOPATHY; ACCURACY; LENIENT;
D O I
10.1161/CIRCEP.124.012842
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Atrial fibrillation (AF) events in cardiac implantable electronic devices (CIEDs) are temporally associated with stroke risk. This study explores temporal differences in AF burden associated with HF hospitalization risk in patients with CIEDs. METHODS: Patients with HF events from the Optum de-identified Electronic Health Records from 2007 to 2021 and 120 days of preceding CIED-derived rhythm data from a linked manufacturer's data warehouse were included. AF burden >= 5.5 h/d was defined as an AF event. The AF event burden in the case period (days 1-30 immediately before the HF event) was considered temporally associated with the HF event and compared with the AF event burden in a temporally dissociated control period (days 91-120 before the HF event). The odds ratio for temporally associated HF events and the odds ratio associated with poorly rate-controlled AF (>110 bpm) were calculated. RESULTS: In total, 7257 HF events with prerequisite CIED data were included; 957 (13.2%) patients had AF events recorded only in either their case (763 [10.5%]) or control (194 [2.7%]) periods, but not both. The odds ratio for a temporally associated HF event was 3.93 (95% CI, 3.36-4.60). This was greater for an HF event with a longer stay of >3 days (odds ratio, 4.51 [95% CI, 3.57-5.68]). In patients with AF during both the control and case periods, poor AF rate control during the case period also increased HF event risk (1.78 [95% CI, 1.22-2.61]). In all, 222 of 4759 (5%) patients without AF events before their HF event had an AF event in the 10 days following. CONCLUSIONS: In a large real-world population of patients with CIED devices, AF burden was associated with HF hospitalization risk in the subsequent 30 days. The risk is increased with AF and an uncontrolled ventricular rate. Our findings support AF monitoring in CIED algorithms to prevent HF admissions.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Association of biomarkers of inflammation with hospitalization for heart failure and death in patients with atrial fibrillation
    Benz, A. P.
    Aeschbacher, S.
    Krisai, P.
    Blum, S.
    Meyre, P.
    Blum, M. R.
    Rodondi, N.
    Di Valentino, M.
    Kobza, R.
    De Perna, M. L.
    Bonati, L. H.
    Beer, J. H.
    Kuehne, M.
    Osswald, S.
    Conen, D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 497 - 497
  • [42] Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices
    Afzal, Muhammad R.
    Kanmanthareddy, Arun
    Earnest, Matthew
    Reddy, Madhu
    Atkins, Donita
    Bommana, Sudharani
    Bartus, Krystof
    Rasekh, Abdi
    Han, Fred
    Badhwar, Nitish
    Cheng, Jie
    Dibiase, Luigi
    Ellis, Christopher R.
    Dawn, Buddhadeb
    Natale, Andrea
    Lee, Randall J.
    Lakkireddy, Dhanunjaya
    HEART RHYTHM, 2015, 12 (01) : 52 - 59
  • [43] Association between COVID-19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices
    Deshmukh, Abhishek J.
    Ahmad, Rimsha
    Cha, Yong-Mei
    Mulpuru, Siva K.
    DeSimone, Christopher V.
    Killu, Ammar M.
    Mullane, Steven
    Harrell, Camden
    Kutyifa, Valentina
    Cheung, Jim W.
    Upadhyay, Gaurav A.
    Piccini, Jonathan P.
    Hayes, David L.
    Madhavan, Malini
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2024, 35 (09) : 1828 - 1836
  • [44] Characteristics of successful termination of atrial fibrillation by atrial antitachycardia pacing in patients with cardiac implantable electronic devices
    Aizawa, Yoshiyasu
    Komura, Satoru
    Kawakami, Emiko
    Watanabe, Shonosuke
    Tanaka, Kazuki
    Kadowaki, Hiromu
    Takagi, Atsushi
    HEART AND VESSELS, 2024, 39 (10) : 884 - 890
  • [45] BURDEN OF ATRIAL FIBRILLATION AND POOR RATE CONTROL DETECTED BY CONTINUOUS MONITORING VIA IMPLANTED DEVICES IDENTIFIES WHEN A PATIENT IS AT RISK FOR HEART FAILURE HOSPITALIZATION
    Sarkar, Shantanu
    Koehler, Jodi
    Crossley, George H.
    Tang, Wai Hong Wilson
    Abraham, William T.
    Whellan, David J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E107 - E107
  • [46] Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction
    Yang, Eunice
    Vaishnav, Joban
    Song, Evelyn
    Lee, Joan
    Schulman, Steven
    Calkins, Hugh
    Berger, Ronald
    Russell, Stuart D.
    Sharma, Kavita
    ESC HEART FAILURE, 2022, 9 (05): : 3918 - 2927
  • [47] Atrial fibrillation burden in chronic heart failure: The role of Cardiac Resynchronization Therapy
    Omar, Razali
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 17 - 17
  • [48] Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with progression of atrial fibrillation burden
    Boriani, G.
    Glotzer, T.
    Ziegler, P.
    De Melis, M.
    Sepsi, M.
    Landolina, M.
    Lunati, M.
    Lewalter, T.
    Camm, J.
    Singer, D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1306 - 1306
  • [49] Defining the gap in heart failure treatment in patients with cardiac implantable electronic devices
    Salimian, Samaneh
    Moghaddam, Nima
    Deyell, Marc W.
    Virani, Sean A.
    Bennett, Matthew T.
    Krahn, Andrew D.
    Andrade, Jason G.
    Hawkins, Nathaniel M.
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (01) : 158 - 166
  • [50] Sacubitril/Valsartan in the Management of Heart Failure Patients with Cardiac Implantable Electronic Devices
    Cheng, Sijing
    Zhang, Nixiao
    Hua, Wei
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (04) : 383 - 393